Children, adolescents and adults living with HIV access testing, know their status and are immediately offered and sustained on affordable quality treatment
The Joint Programme continues to play a pivotal role in global efforts to rapidly accelerate testing and treatment access. Eight countries achieved and 20 countries almost achieved the 90–90–90 targets for testing, treatment access and viral suppression of HIV at the end of 2020. While 37.7 million people globally were living with HIV in 2020, 28.2 million people were accessing antiretroviral therapy (ART) by June 2021. Considerable gaps remain and COVID-19 further slowed progress.
Important disparities in treatment access persist, as only 54% of children (0–14 years-old) were receiving ART at the end of 2020. While more women than men were on treatment in 2020, AIDS remains one of the leading causes of death for women of reproductive age (15–49 years), particularly in sub-Saharan Africa. To reach the new global 95–95–95 targets, a redoubling of efforts is required to avoid the worst-case scenario of 7.7 million HIV-related deaths over the next 10 years. Legal and societal barriers, unequal gender norms, gender inequalities, including wide-spread violence against women, continue to undermine the progress.
In 2021 and through the different stages of the COVID-19 pandemic, the Joint Programme sustained essential HIV and health services and continued the "treat all" policy implementation. Innovative and targeted HIV testing approaches were introduced and renewed focus was put on service delivery for children. Access to medicines and commodities remained a priority, as did the strengthening of HIV services in humanitarian and emergency settings.
Find more details in the SRA report.
Outputs 2016-2021
1.1 | Innovative HIV testing and counselling programmes |
1.2 | Access to treatment cascade |
1.3 | Testing for children and adolescents |
1.4 | Fast-track HIV services in high-burden cities |
1.5 | HIV services in humanitarian emergencies |
OUTPUT INDICATORS |
Targets and milestones | 2021 Progress |
---|---|---|
Percentage of countries with selected HIV Testing Services in place. |
2021: 90% 2019: 80% 2017: 70% |
70% [61/87] |
Percentage of countries adopting WHO HIV treatment guidelines. |
2021: 80% 2019: 60% 2017: 50% |
66% [57/87] |
Percentage of countries adopting quality healthcare services for children and adolescents |
2021: 90% 2019: 80% 2017: 60% |
62% [54/87] |
Percentage of countries with a plan and allocated resources to achieve Fast-Track targets in high-burden countries |
2021: 90% 2019: 80% 2017: 60% |
42% [33/78] |
Percentage of countries where HIV is integrated in national emergency preparedness and response plans |
2021: 90% 2019: 85% 2017: 80% |
75% [52/69] |
Percentage of countries offering HIV-related services for populations affected by humanitarian emergencies- disaggregated by the following populations:
|
2021: 90% 2019: 85% 2017: 80% |
|
Data source: 2021 JPMS country reports. |